ASPI

ASPI R&D to Revenue

51.82%Fiscal year

Period ending:

ASPI FY R&D/Revenue%
ASPI FY R&D/Revenue197.76%-21.19%
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

ASPI r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 6 observations from Dec 31, 2019 to Dec 31, 2025.

Asp Isotopes Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
51.8177%
75.7481%
176.567%
0%
0%
0%

Compare r&d to revenue

All ASPI financial metrics · ASPI stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.